{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:01:07Z","timestamp":1790452867555,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108846","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:47:21Z","timestamp":1790135241000},"page":"108846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunological evaluation of Brucella antigens formulated with two agonists of toll-like receptor 4 and 3 against brucellosis in BALB\/c mice"],"prefix":"10.1016","volume":"221","author":[{"given":"Zohre","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi-Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micpath.2026.108846_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108846_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijfoodmicro.2018.12.009","article-title":"Human brucellosis caused by raw dairy products: a review on the occurrence, major risk factors and prevention","volume":"292","author":"Dadar","year":"2019","journal-title":"Int. J. Food Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.66585\/ohmi.2026.2.0013","article-title":"One health approach in human brucellosis: a comprehensive review of epidemiology, transmission, diagnosis, management, and control strategies","volume":"2","author":"Patel","year":"2026","journal-title":"One Health Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.micpath.2026.108846_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.36519\/idcm.2026.984","article-title":"Retrospective analysis of epidemiologic, clinical, and laboratory findings of patients diagnosed with brucellosis and review of the literature","volume":"8","author":"Arslan","year":"2026","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2026.108846_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1136674","article-title":"Research progress on complications of B rucellosis","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108846_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001929","article-title":"Clinical manifestations of human brucellosis: a systematic review and meta-analysis","volume":"6","author":"Dean","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib7","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calder\u00f3n","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet. Res."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front. Biol."},{"issue":"10","key":"10.1016\/j.micpath.2026.108846_bib10","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.micpath.2026.108846_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections","volume":"123","author":"Abkar","year":"2015","journal-title":"Apmis"},{"issue":"49","key":"10.1016\/j.micpath.2026.108846_bib12","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.micpath.2026.108846_bib13","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4014\/jmb.1505.05028","article-title":"Immunization of mice with recombinant Brucella abortus organic hydroperoxide resistance (Ohr) protein protects against a virulent Brucella abortus 544 infection","volume":"26","author":"Hop","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108846_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11250-018-1517-7","article-title":"Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB\/c mice","volume":"50","author":"Lin","year":"2018","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.micpath.2026.108846_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fimmu.2017.00125","article-title":"Immunogenicity of a multi-epitope dna vaccine encoding epitopes from Cu\u2013Zn superoxide dismutase and open reading frames of Brucella abortus in mice","volume":"8","author":"Escalona","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib18","article-title":"Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice","volume":"2012","author":"Avila-Calderon","year":"2012","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.micpath.2026.108846_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105829","article-title":"Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I: c against Brucella melitensis and Brucella abortus infection","volume":"75","author":"Sadeghi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108846_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113172","article-title":"Brucella antigens (BhuA, 7\u03b1-HSDH, FliC) in poly I: c adjuvant as potential vaccine candidates against brucellosis","volume":"500","author":"Sadeghi","year":"2022","journal-title":"J. Immunol. Methods"},{"issue":"17","key":"10.1016\/j.micpath.2026.108846_bib21","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micpath.2026.108846_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.22","article-title":"Toll\u2010like receptors: the Swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2026.108846_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14760584.2016.1124763","article-title":"Human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases","volume":"15","author":"Skinner","year":"2016","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.micpath.2026.108846_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2018.06.004","article-title":"MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine","volume":"156","author":"Ko","year":"2018","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.micpath.2026.108846_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev. Vaccine"},{"issue":"10","key":"10.1016\/j.micpath.2026.108846_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly (I: C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.micpath.2026.108846_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly (I: C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.micpath.2026.108846_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/14760584.2.2.219","article-title":"Enhancement of antigen-specific immunity via the TLR4 ligands MPL\u2122 adjuvant and Ribi. 529","volume":"2","author":"Evans","year":"2003","journal-title":"Expert Rev. Vaccine"},{"issue":"6","key":"10.1016\/j.micpath.2026.108846_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1189\/jlb.0305172","article-title":"The low-toxicity versions of LPS, MPL\u00ae adjuvant and RC529, are efficient adjuvants for CD4+ T cells","volume":"78","author":"Thompson","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108846_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"O'Hagan","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.micpath.2026.108846_bib32","series-title":"Adjuvants for Cancer Vaccines. Seminars in Immunology","year":"2010"},{"issue":"4","key":"10.1016\/j.micpath.2026.108846_bib33","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.xphs.2022.12.025","article-title":"Multi-epitope vaccine candidates associated with mannosylated chitosan and LPS conjugated chitosan nanoparticles against Brucella infection","volume":"112","author":"Sadeghi","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2026.108846_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108846_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295398","article-title":"Brucellosis: epidemiology, pathogenesis, diagnosis and treatment\u2013a comprehensive review","volume":"55","author":"Qureshi","year":"2023","journal-title":"Ann. Med."},{"issue":"6","key":"10.1016\/j.micpath.2026.108846_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00203-026-04796-8","article-title":"Brucellosis vaccine development: immunological mechanisms, animal models, and future directions","volume":"208","author":"Zhang","year":"2026","journal-title":"Arch. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108846_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/vaccines14050409","article-title":"Modern strategies for brucellosis vaccination: from traditional approaches to innovative platforms","volume":"14","author":"Assanzhanova","year":"2026","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib38","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/s41598-017-02804-y","article-title":"Combinatorial delivery of dual and triple TLR agonists via polymeric pathogen-like particles synergistically enhances innate and adaptive immune responses","volume":"7","author":"Madan-Lala","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/erv.10.154","article-title":"Combination adjuvants: the next generation of adjuvants?","volume":"10","author":"Mutwiri","year":"2011","journal-title":"Expert Rev. Vaccine"},{"issue":"6","key":"10.1016\/j.micpath.2026.108846_bib40","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella\u2013host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.micpath.2026.108846_bib41","series-title":"Immunity to Brucellosis","author":"Skendros","year":"2013"},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib42","article-title":"Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF\/MyD88-NF-\u03baB signaling pathway","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.micpath.2026.108846_bib43","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1128\/IAI.69.10.6541-6544.2001","article-title":"Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection","volume":"69","author":"Pasquali","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2026.108846_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.micpath.2026.108846_bib47","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.4049\/jimmunol.1302561","article-title":"Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis","volume":"192","author":"Vitry","year":"2014","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108846_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3855\/jidc.6625","article-title":"Host response to Brucella infection: review and future perspective","volume":"9","author":"Elfaki","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"issue":"6","key":"10.1016\/j.micpath.2026.108846_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180073","article-title":"Combination of poly I: c and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo","volume":"12","author":"Weir","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micpath.2026.108846_bib50","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.03309-13","article-title":"Toll-like receptor 7\/8 (TLR7\/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques","volume":"88","author":"Moody","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108846_bib51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI39293","article-title":"Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice","volume":"120","author":"Zhu","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.micpath.2026.108846_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39210-6","article-title":"Adjuvant effects of combination monophosphoryl lipid A and poly I: c on antigen-specific immune responses and protective efficacy of influenza vaccines","volume":"13","author":"Le","year":"2023","journal-title":"Sci. Rep."},{"issue":"45","key":"10.1016\/j.micpath.2026.108846_bib53","doi-asserted-by":"crossref","first-page":"13994","DOI":"10.1073\/pnas.1510760112","article-title":"Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation","volume":"112","author":"Hu","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2026.108846_bib54","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108846_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat. Rev. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:57:04Z","timestamp":1790452624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S0882401026005723"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108846","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological evaluation of Brucella antigens formulated with two agonists of toll-like receptor 4 and 3 against brucellosis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108846"}}